Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme

  1. Zhening Zhang
  2. Wenguang G Liang
  3. Lucas J Bailey
  4. Yong Zi Tan
  5. Hui Wei
  6. Andrew Wang
  7. Mara Farcasanu
  8. Virgil A Woods
  9. Lauren A McCord
  10. David Lee
  11. Weifeng Shang
  12. Rebecca Deprez-Poulain
  13. Benoit Deprez
  14. David R Liu
  15. Akiko Koide
  16. Shohei Koide
  17. Anthony A Kossiakoff
  18. Sheng Li  Is a corresponding author
  19. Bridget Carragher  Is a corresponding author
  20. Clinton S Potter  Is a corresponding author
  21. Wei-Jen Tang  Is a corresponding author
  1. New York Structural Biology Center, United States
  2. The University of Chicago, United States
  3. University of California, San Diego, United States
  4. Argonne National Laboratory, United States
  5. Université de Lille, France
  6. Harvard University, United States
  7. New York University, United States

Abstract

Insulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type 2 diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes peptides that tend to form amyloid fibrils remained unsolved. We used cryoEM to understand both the apo- and insulin-bound dimeric IDE states, revealing that IDE displays a large opening between the homologous ~55 kDa N- and C-terminal halves to allow selective substrate capture based on size and charge complementarity. We also used cryoEM, X-ray crystallography, SAXS, and HDX-MS to elucidate the molecular basis of how amyloidogenic peptides stabilize the disordered IDE catalytic cleft, thereby inducing selective degradation by substrate-assisted catalysis. Furthermore, our insulin-bound IDE structures explain how IDE processively degrades insulin by stochastically cutting either chain without breaking disulfide bonds. Together, our studies provide a mechanism for how IDE selectively degrades amyloidogenic peptides and offers structural insights for developing IDE-based therapies.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Zhening Zhang

    National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Wenguang G Liang

    Ben-May Institute for Cancer Research, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Lucas J Bailey

    Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yong Zi Tan

    National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6656-6320
  5. Hui Wei

    National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Andrew Wang

    Ben-May Institute for Cancer Research, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Mara Farcasanu

    Ben-May Institute for Cancer Research, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Virgil A Woods

    Department of Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Lauren A McCord

    Ben-May Institute for Cancer Research, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. David Lee

    Department of Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Weifeng Shang

    BioCAT, Argonne National Laboratory, Argonne, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Rebecca Deprez-Poulain

    U1177 - Drug and Molecules for Living Systems, Université de Lille, Lille, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Benoit Deprez

    U1177 - Drug and Molecules for Living Systems, Université de Lille, Lille, France
    Competing interests
    The authors declare that no competing interests exist.
  14. David R Liu

    Department of Chemistry and Chemical Biology, Harvard University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Akiko Koide

    Perlmutter Cancer Center, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Shohei Koide

    Perlmutter Cancer Center, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Anthony A Kossiakoff

    Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Sheng Li

    Department of Medicine, University of California, San Diego, La Jolla, United States
    For correspondence
    s4li@ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
  19. Bridget Carragher

    National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States
    For correspondence
    bcarr@nysbc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0624-5020
  20. Clinton S Potter

    National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States
    For correspondence
    cpotter@nysbc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2394-0831
  21. Wei-Jen Tang

    Ben-May Institute for Cancer Research, The University of Chicago, Chicago, United States
    For correspondence
    wtang@bsd.uchicago.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8267-8995

Funding

National Institutes of Health (GM81539)

  • Wei-Jen Tang

Defense Advanced Research Projects Agency (N66001-14-2-4053)

  • David R Liu

Simons Foundation (349247)

  • Bridget Carragher
  • Clinton S Potter

National Institutes of Health (GM121964)

  • Wei-Jen Tang

National Institutes of Health (GM103310)

  • Bridget Carragher
  • Clinton S Potter

National Institutes of Health (R35 GM118062)

  • David R Liu

Howard Hughes Medical Institute

  • David R Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Sriram Subramaniam, National Cancer Institute, United States

Version history

  1. Received: November 15, 2017
  2. Accepted: March 28, 2018
  3. Accepted Manuscript published: March 29, 2018 (version 1)
  4. Version of Record published: April 20, 2018 (version 2)

Copyright

© 2018, Zhang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,824
    views
  • 733
    downloads
  • 47
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhening Zhang
  2. Wenguang G Liang
  3. Lucas J Bailey
  4. Yong Zi Tan
  5. Hui Wei
  6. Andrew Wang
  7. Mara Farcasanu
  8. Virgil A Woods
  9. Lauren A McCord
  10. David Lee
  11. Weifeng Shang
  12. Rebecca Deprez-Poulain
  13. Benoit Deprez
  14. David R Liu
  15. Akiko Koide
  16. Shohei Koide
  17. Anthony A Kossiakoff
  18. Sheng Li
  19. Bridget Carragher
  20. Clinton S Potter
  21. Wei-Jen Tang
(2018)
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
eLife 7:e33572.
https://doi.org/10.7554/eLife.33572

Share this article

https://doi.org/10.7554/eLife.33572

Further reading

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Aaron JO Lewis, Frank Zhong ... Ramanujan S Hegde
    Research Article

    The protein translocon at the endoplasmic reticulum comprises the Sec61 translocation channel and numerous accessory factors that collectively facilitate the biogenesis of secretory and membrane proteins. Here, we leveraged recent advances in cryo-electron microscopy (cryo-EM) and structure prediction to derive insights into several novel configurations of the ribosome-translocon complex. We show how a transmembrane domain (TMD) in a looped configuration passes through the Sec61 lateral gate during membrane insertion; how a nascent chain can bind and constrain the conformation of ribosomal protein uL22; and how the translocon-associated protein (TRAP) complex can adjust its position during different stages of protein biogenesis. Most unexpectedly, we find that a large proportion of translocon complexes contains RAMP4 intercalated into Sec61’s lateral gate, widening Sec61’s central pore and contributing to its hydrophilic interior. These structures lead to mechanistic hypotheses for translocon function and highlight a remarkably plastic machinery whose conformations and composition adjust dynamically to its diverse range of substrates.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Roberto Efraín Díaz, Andrew K Ecker ... James S Fraser
    Research Article

    Chitin is an abundant biopolymer and pathogen-associated molecular pattern that stimulates a host innate immune response. Mammals express chitin-binding and chitin-degrading proteins to remove chitin from the body. One of these proteins, Acidic Mammalian Chitinase (AMCase), is an enzyme known for its ability to function under acidic conditions in the stomach but is also active in tissues with more neutral pHs, such as the lung. Here, we used a combination of biochemical, structural, and computational modeling approaches to examine how the mouse homolog (mAMCase) can act in both acidic and neutral environments. We measured kinetic properties of mAMCase activity across a broad pH range, quantifying its unusual dual activity optima at pH 2 and 7. We also solved high-resolution crystal structures of mAMCase in complex with oligomeric GlcNAcn, the building block of chitin, where we identified extensive conformational ligand heterogeneity. Leveraging these data, we conducted molecular dynamics simulations that suggest how a key catalytic residue could be protonated via distinct mechanisms in each of the two environmental pH ranges. These results integrate structural, biochemical, and computational approaches to deliver a more complete understanding of the catalytic mechanism governing mAMCase activity at different pH. Engineering proteins with tunable pH optima may provide new opportunities to develop improved enzyme variants, including AMCase, for therapeutic purposes in chitin degradation.